ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Accuray Incorporated (ARAY) Report Updated: Oct 27, 2014 | Print This Page

Get more stock ratings by Louis Navellier

Accuray Incorporated (ARAY)

Rating: Hold Volatility: Moderate
Total Grade: C Industry: Health Care Equipment & Supplies
Competitors: NUVA, NVCN, MSON, ZLTQ

Stock Analysis

Rating: Monthly View

A
B
C
D
F
November December January February March April May June July August September October

Rating: Weekly View

This Week: C down no change
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

Accuray Incorporated© quotemedia

Company Profile

Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors in the body. It offers CyberKnife system, an image-guided robotic radiosurgery system used to deliver radiosurgery for the treatment of solid tumors. This system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure enabling the delivery of radiation with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.

Recent News: Accuray Incorporated